rPeptide

rPeptide is a privately-held, revenue-generating research reagent and contract service provider headquartered in Bogart, Georgia. It has established a niche as a specialized supplier of high-purity, recombinant tools for neurodegenerative disease research, with a product portfolio centered on key targets like beta-amyloid, tau, and alpha-synuclein. The company leverages expertise in difficult protein expression to offer custom services and has expanded its catalog to include coronavirus research tools. Its business model is built on selling standardized and custom research products directly to the global life science research community.

Recombinant protein expression and purification platform specializing in hard-to-express proteins, isotopic labeling (C13/N15), and generation of standardized preformed fibrils for neurodegenerative disease research.

rPeptide competes in the fragmented life science research reagents market. It faces competition from giants like Thermo Fisher Scientific and Merck, as well as specialized neuroscience-focused suppliers like AnaSpec and SignalChem. Its competitive advantage lies in its deep specialization in recombinant neurodegenerative disease proteins and preformed fibrils, areas where technical expertise creates a barrier to entry.